Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

2338 ARTÍCULOS , VIENDO DEL 1771 AL 1785

Neuroanatomical background and functional considerations for stereotactic interventions in the H fields of Forel

Neudorfer C, Maarouf M.

Brain Struct Funct. 2018 Jan;223(1):17-30. doi: 10.1007/s00429-017-1570-4. Epub 2017 Nov 20.

Hyperkinetic Movement Disorder Emergencies

Cossu G, Colosimo C.

Curr Neurol Neurosci Rep. 2017 Jan;17(1):6. doi: 10.1007/s11910-017-0712-7.

Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome

Paton DM.

Drugs Today (Barc). 2017 Feb;53(2):89-102. doi: 10.1358/dot.2017.53.2.2589164.

Neurological Disorders in Medical Use of Cannabis: An Update

Solimini R, Rotolo MC, Pichini S, Pacifici R.

CNS Neurol Disord Drug Targets. 2017;16(5):527-533. doi: 10.2174/1871527316666170413105421.

Habituation is altered in neuropsychiatric disorders-A comprehensive review with recommendations for experimental design and analysis

McDiarmid TA, Bernardos AC, Rankin CH.

Neurosci Biobehav Rev. 2017 Sep;80:286-305. doi: 10.1016/j.neubiorev.2017.05.028. Epub 2017 Jun 1.

Seventy Years with the Globus Pallidus: Pallidal Surgery for Movement Disorders Between 1947 and 2017

Cif L, Hariz M.

Mov Disord. 2017 Jul;32(7):972-982. doi: 10.1002/mds.27054. Epub 2017 Jun 7.

[Movement disorders: An update]

Béreau M, Tranchant C.

Rev Med Interne. 2018 Aug;39(8):641-649. doi: 10.1016/j.revmed.2017.09.001. Epub 2017 Oct 16.

A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders

Lim K, See YM, Lee J.

Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):301-312. doi: 10.9758/cpn.2017.15.4.301.

Increased Reporting of Exclusionary Diagnoses Inflate Apparent Reductions in Long-Stay Antipsychotic Prescribing

Winter JD, Kerns JW, Winter KM, Sabo RT.

Clin Gerontol. 2019 May-Jun;42(3):297-301. doi: 10.1080/07317115.2017.1395378. Epub 2017 Dec 5.

Movement Disorders in Women

Baker JM, Hung AY.

Semin Neurol. 2017 Dec;37(6):653-660. doi: 10.1055/s-0037-1608845. Epub 2017 Dec 21.

Psychiatric Treatment and Management of Psychiatric Comorbidities of Movement Disorders

Walsh KH, Soe K, Sarawgi S.

Semin Pediatr Neurol. 2018 Apr;25:123-135. doi: 10.1016/j.spen.2017.12.002. Epub 2017 Dec 20.

Tics as an initial manifestation of juvenile Huntington's disease: case report and literature review

Cui SS, Ren RJ, Wang Y, Wang G, Chen SD.

BMC Neurol. 2017 Aug 8;17(1):152. doi: 10.1186/s12883-017-0923-1.

Recent Advances in Understanding and Managing Tourette Syndrome

Thenganatt MA, Jankovic J.

F1000Res. 2016 Feb 9;5:F1000 Faculty Rev-152. doi: 10.12688/f1000research.7424.1. eCollection 2016.

A Review and Update on Tourette Syndrome: Where Is the Field Headed?

Gunduz A, Okun MS.

Curr Neurol Neurosci Rep. 2016 Apr;16(4):37. doi: 10.1007/s11910-016-0633-x.

Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defects

Vilboux T, Malicdan MC, Chang YM, Guo J, Zerfas PM, Stephen J, Cullinane AR, Bryant J, Fischer R, Brooks BP, Zein WM, Wiggs EA, Zalewski CK, Poretti A, Bryan MM, Vemulapalli M, Mullikin JC, Kirby M, Anderson SM; NISC Comparative Sequencing Program; Huizing M, Toro C, Gahl WA, Gunay-Aygun M.

J Med Genet. 2016 May;53(5):318-29. doi: 10.1136/jmedgenet-2015-103416. Epub 2016 Jan 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias